NO20010329L - Treatment of autoimmune states with copolymer 1 and related copolymers and peptides - Google Patents

Treatment of autoimmune states with copolymer 1 and related copolymers and peptides

Info

Publication number
NO20010329L
NO20010329L NO20010329A NO20010329A NO20010329L NO 20010329 L NO20010329 L NO 20010329L NO 20010329 A NO20010329 A NO 20010329A NO 20010329 A NO20010329 A NO 20010329A NO 20010329 L NO20010329 L NO 20010329L
Authority
NO
Norway
Prior art keywords
peptides
copolymer
treatment
related copolymers
autoimmune states
Prior art date
Application number
NO20010329A
Other languages
Norwegian (no)
Other versions
NO20010329D0 (en
NO328228B1 (en
Inventor
Rina Aharoni
Dvora Teitelbaum
Ruth Arnon
Michael Sela
Masha Fridkis-Hareli
Jack L Strominger
Original Assignee
Yeda Res & Dev
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1999/016747 external-priority patent/WO2000005250A1/en
Application filed by Yeda Res & Dev, Harvard College filed Critical Yeda Res & Dev
Publication of NO20010329D0 publication Critical patent/NO20010329D0/en
Publication of NO20010329L publication Critical patent/NO20010329L/en
Publication of NO328228B1 publication Critical patent/NO328228B1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Polyamides (AREA)
NO20010329A 1998-07-23 2001-01-19 Use of a mixture of polypeptides for the preparation of a pharmaceutical composition for the treatment of an autoimmune disease other than MS. NO328228B1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US9385998P 1998-07-23 1998-07-23
US10182598P 1998-09-25 1998-09-25
US10296098P 1998-10-02 1998-10-02
US10818498P 1998-11-12 1998-11-12
US12367599P 1999-03-09 1999-03-09
PCT/US1999/016747 WO2000005250A1 (en) 1998-07-23 1999-07-23 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides

Publications (3)

Publication Number Publication Date
NO20010329D0 NO20010329D0 (en) 2001-01-19
NO20010329L true NO20010329L (en) 2001-03-08
NO328228B1 NO328228B1 (en) 2010-01-11

Family

ID=27536686

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010329A NO328228B1 (en) 1998-07-23 2001-01-19 Use of a mixture of polypeptides for the preparation of a pharmaceutical composition for the treatment of an autoimmune disease other than MS.

Country Status (4)

Country Link
JP (1) JP4800481B2 (en)
HU (1) HUP0202653A3 (en)
NO (1) NO328228B1 (en)
NZ (1) NZ509901A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ551236A (en) * 2004-05-07 2010-11-26 Peptimmune Inc Methods of treating disease with random copolymers
EP2016095A2 (en) * 2006-04-13 2009-01-21 Peptimmune, Inc. Methods for designing and synthesizing directed sequence polymer compositions via the directed expansion of epitope permeability
CA3137809A1 (en) * 2019-08-09 2021-02-18 Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. Hla-dr/cii peptide complexes for treating arthritis

Also Published As

Publication number Publication date
NO20010329D0 (en) 2001-01-19
HUP0202653A2 (en) 2002-12-28
NO328228B1 (en) 2010-01-11
HUP0202653A3 (en) 2007-11-28
JP4800481B2 (en) 2011-10-26
NZ509901A (en) 2003-10-31
JP2002521387A (en) 2002-07-16

Similar Documents

Publication Publication Date Title
EP1098902A4 (en) Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides
DE69119688T2 (en) Graft copolymers and graft copolymer / protein compositions
DE69433657D1 (en) Ethylene-alpha-olefin copolymers and molded parts made from them
DE69717223D1 (en) Fluorocyanate and fluorocarbamate monomers and derived polymers
DE69408897T2 (en) Absorbable block copolymers and surgical articles made therefrom
DE69511864D1 (en) ACRYLATE COPOLYMERS AND THESE POLYMER COMPOSITIONS
DE69530363D1 (en) Absorbable polyetherestercarbonate block copolymers and surgical articles made therefrom
NO20003488D0 (en) Homopolymers and copolymers of ethylene
DE69732310D1 (en) HALOGENATED ACRYLATES AND DERIVED POLYMERS
NO983147L (en) Use of an antagonist of PPAR- <alfa> and PPAR- <gamma> in the treatment of syndrome X
ATE193712T1 (en) VINYLAROMATE BLOCK COPOLYMERS AND COMPOSITIONS CONTAINING THE SAME
NO20001786D0 (en) Four component copolymers and the intraocular lens five-positioned therefrom
PL330713A1 (en) Spry-dried compositions of polymers and treatment methods
DE69427434D1 (en) Liquid copolymers of e-caprolactone and lactide
ZA952096B (en) Copolymers of 1,4-dioxepan-2-one and 15812-tetraoxacy-clotetradecane-7-14-dione
ATE194640T1 (en) BLENDS OF ELASTOMIC BLOCK COPOLYMERS AND INTERPOLYMERS OF ALIPHATIC ALPHA-OLEFINS, MONOVINYLIDE AROMATIC MONOMERS AND/OR HINDERED ALIPHATIC VINYLIDE MONOMERS
ZA986671B (en) Block copolymers and preparation thereof
DE69608692T2 (en) IONOMER WITH IMPROVED HIGH TEMPERATURE PROPERTIES AND IMPROVED MOLDABILITY
DE69315593T2 (en) FLUORINATED MONOMERS AND POLYMERS
DE60004989D1 (en) FLUOROALKAN SULFONYLAZIDE MONOMERS AND COPOLYMERS THEREOF
BR9609135A (en) Metallization and functionalization of polymers and copolymers
NO961790L (en) Combination of appliance base and insert part
NO990836D0 (en) Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
DE69703602D1 (en) Copolymers containing fluorine and ethylene
NO20010329D0 (en) Treatment of autoimmune states with copolymer 1 and related copolymers and peptides

Legal Events

Date Code Title Description
MK1K Patent expired